Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C201147> ?p ?o ?g. }
- NCIT_C201147 IAO_0000115 "A regimen consisting of rituximab and maximum-strength cyclophosphamide, doxorubicin, prednisone and vincristine that may be used for the treatment of mantle cell lymphoma (MCL)." @default.
- NCIT_C201147 NCIT_NHC0 "C201147" @default.
- NCIT_C201147 NCIT_P106 "Therapeutic or Preventive Procedure" @default.
- NCIT_C201147 NCIT_P108 "R-maxi-CHOP Regimen" @default.
- NCIT_C201147 NCIT_R123 NCIT_C129821 @default.
- NCIT_C201147 NCIT_R123 NCIT_C129822 @default.
- NCIT_C201147 NCIT_R123 NCIT_C129824 @default.
- NCIT_C201147 NCIT_R123 NCIT_C129825 @default.
- NCIT_C201147 NCIT_R123 NCIT_C1326 @default.
- NCIT_C201147 NCIT_R123 NCIT_C141215 @default.
- NCIT_C201147 NCIT_R123 NCIT_C147908 @default.
- NCIT_C201147 NCIT_R123 NCIT_C1590 @default.
- NCIT_C201147 NCIT_R123 NCIT_C1594 @default.
- NCIT_C201147 NCIT_R123 NCIT_C1636 @default.
- NCIT_C201147 NCIT_R123 NCIT_C163758 @default.
- NCIT_C201147 NCIT_R123 NCIT_C164034 @default.
- NCIT_C201147 NCIT_R123 NCIT_C1702 @default.
- NCIT_C201147 NCIT_R123 NCIT_C1739 @default.
- NCIT_C201147 NCIT_R123 NCIT_C1748 @default.
- NCIT_C201147 NCIT_R123 NCIT_C186664 @default.
- NCIT_C201147 NCIT_R123 NCIT_C1907 @default.
- NCIT_C201147 NCIT_R123 NCIT_C1908 @default.
- NCIT_C201147 NCIT_R123 NCIT_C1909 @default.
- NCIT_C201147 NCIT_R123 NCIT_C1913 @default.
- NCIT_C201147 NCIT_R123 NCIT_C1916 @default.
- NCIT_C201147 NCIT_R123 NCIT_C1931 @default.
- NCIT_C201147 NCIT_R123 NCIT_C1968 @default.
- NCIT_C201147 NCIT_R123 NCIT_C20401 @default.
- NCIT_C201147 NCIT_R123 NCIT_C211 @default.
- NCIT_C201147 NCIT_R123 NCIT_C2114 @default.
- NCIT_C201147 NCIT_R123 NCIT_C2115 @default.
- NCIT_C201147 NCIT_R123 NCIT_C2161 @default.
- NCIT_C201147 NCIT_R123 NCIT_C2189 @default.
- NCIT_C201147 NCIT_R123 NCIT_C221 @default.
- NCIT_C201147 NCIT_R123 NCIT_C2364 @default.
- NCIT_C201147 NCIT_R123 NCIT_C259 @default.
- NCIT_C201147 NCIT_R123 NCIT_C25974 @default.
- NCIT_C201147 NCIT_R123 NCIT_C273 @default.
- NCIT_C201147 NCIT_R123 NCIT_C274 @default.
- NCIT_C201147 NCIT_R123 NCIT_C2842 @default.
- NCIT_C201147 NCIT_R123 NCIT_C307 @default.
- NCIT_C201147 NCIT_R123 NCIT_C308 @default.
- NCIT_C201147 NCIT_R123 NCIT_C405 @default.
- NCIT_C201147 NCIT_R123 NCIT_C471 @default.
- NCIT_C201147 NCIT_R123 NCIT_C521 @default.
- NCIT_C201147 NCIT_R123 NCIT_C548 @default.
- NCIT_C201147 NCIT_R123 NCIT_C574 @default.
- NCIT_C201147 NCIT_R123 NCIT_C67422 @default.
- NCIT_C201147 NCIT_R123 NCIT_C67502 @default.
- NCIT_C201147 NCIT_R123 NCIT_C697 @default.
- NCIT_C201147 NCIT_R123 NCIT_C718 @default.
- NCIT_C201147 NCIT_R123 NCIT_C770 @default.
- NCIT_C201147 NCIT_R123 NCIT_C932 @default.
- NCIT_C201147 NCIT_R172 NCIT_C179052 @default.
- NCIT_C201147 NCIT_R172 NCIT_C188021 @default.
- NCIT_C201147 NCIT_R172 NCIT_C26323 @default.
- NCIT_C201147 NCIT_R172 NCIT_C27134 @default.
- NCIT_C201147 NCIT_R172 NCIT_C27551 @default.
- NCIT_C201147 NCIT_R172 NCIT_C27907 @default.
- NCIT_C201147 NCIT_R172 NCIT_C27910 @default.
- NCIT_C201147 NCIT_R172 NCIT_C2991 @default.
- NCIT_C201147 NCIT_R172 NCIT_C3208 @default.
- NCIT_C201147 NCIT_R172 NCIT_C3211 @default.
- NCIT_C201147 NCIT_R172 NCIT_C3262 @default.
- NCIT_C201147 NCIT_R172 NCIT_C3263 @default.
- NCIT_C201147 NCIT_R172 NCIT_C3457 @default.
- NCIT_C201147 NCIT_R172 NCIT_C35813 @default.
- NCIT_C201147 NCIT_R172 NCIT_C35814 @default.
- NCIT_C201147 NCIT_R172 NCIT_C4337 @default.
- NCIT_C201147 NCIT_R172 NCIT_C4741 @default.
- NCIT_C201147 NCIT_R172 NCIT_C7056 @default.
- NCIT_C201147 NCIT_R172 NCIT_C7057 @default.
- NCIT_C201147 NCIT_R172 NCIT_C7062 @default.
- NCIT_C201147 NCIT_R172 NCIT_C7065 @default.
- NCIT_C201147 NCIT_R172 NCIT_C9305 @default.
- NCIT_C201147 NCIT_R172 NCIT_C9308 @default.
- NCIT_C201147 normalizedInformationContent "100" @default.
- NCIT_C201147 referenceCount "1" @default.
- NCIT_C201147 hasExactSynonym "R-maxi-CHOP Regimen" @default.
- NCIT_C201147 hasExactSynonym "Rituximab Plus Maximum-strength CHOP Regimen" @default.
- NCIT_C201147 hasExactSynonym "Rituximab Plus Maximum-strength Cyclophosphamide/Doxorubicin/Prednisone/Vincristine Regimen" @default.
- NCIT_C201147 hasExactSynonym "Rituximab Plus Maximum-strength Cyclophosphamide/Doxorubicin/Vincristine/Prednisone Regimen" @default.
- NCIT_C201147 hasExactSynonym "Rituximab Plus Maximum-strength Cyclophosphamide/Hydroxydaunorubicin/Oncovin/Prednisone Regimen" @default.
- NCIT_C201147 hasExactSynonym "Rituximab/Maximum-strength CHOP Regimen" @default.
- NCIT_C201147 hasExactSynonym "Rituximab/Maximum-strength Cyclophosphamide-Doxorubicin-Vincristine-Prednisone Regimen" @default.
- NCIT_C201147 inSubset NCIT_C160950 @default.
- NCIT_C201147 inSubset NCIT_C160952 @default.
- NCIT_C201147 type Class @default.
- NCIT_C201147 isDefinedBy ncit.owl @default.
- NCIT_C201147 label "R-maxi-CHOP Regimen" @default.
- NCIT_C201147 subClassOf B06d923f692aa3c76b6352e76cbda3409 @default.
- NCIT_C201147 subClassOf B0bd5948e57c6b366ed4d81a49ed1135b @default.
- NCIT_C201147 subClassOf B1d353983562999b6355f0fd51bff7d26 @default.
- NCIT_C201147 subClassOf B31eb1d679a0cebccc834f9d545c9f38f @default.
- NCIT_C201147 subClassOf B55700539916dccd3a7c51479931df76f @default.
- NCIT_C201147 subClassOf B60903072c955a1605d1e943cf991e8f8 @default.
- NCIT_C201147 subClassOf B7df650f4f4345de05400a4833058a731 @default.
- NCIT_C201147 subClassOf B8875a186c252ff04cf4e5bce7f5e8de7 @default.
- NCIT_C201147 subClassOf B993c6d749aa174152adfb4b1e4bcdafb @default.
- NCIT_C201147 subClassOf Bbb2ef444d36704ee282cd91a9d041e55 @default.